Skip to search formSkip to main contentSkip to account menu

Cyclazocine

Known as: 2,6-Methano-3-benzazocin-8-ol, 3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-, Cyclazocine [Chemical/Ingredient] 
An analgesic with mixed narcotic agonist-antagonist properties.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1995
Highly Cited
1995
The ability of mu-opioid agonists to activate G proteins has been demonstrated by studying the binding of the GTP analogue… 
Review
1988
Review
1988
Naltrexone is a long acting competitive antagonist at opioid receptors which blocks the subjective and objective responses… 
Highly Cited
1988
Highly Cited
1988
Abstract: The potent noncompetitive N‐methyl‐D‐aspartate (NMDA) receptor antagonist [3H]MK‐801 bound with nanomolar affinity to… 
Highly Cited
1986
Highly Cited
1986
The kappa opioid agonists are analgesics that seem to be free of undesired morphine-like effects. Their dysphoric actions… 
Highly Cited
1982
Highly Cited
1982
  • T. Su
  • The Journal of pharmacology and experimental…
  • 1982
  • Corpus ID: 23837713
A portion of the specific binding of tritiated SKF-10047 to the guinea-pig brain suspension of the particulate fraction is not… 
Highly Cited
1979
Highly Cited
1976
Highly Cited
1976
A series of morphine-like and nalorphine-like drugs were studied in the nondependent, morphine-dependent and cyclazocine… 
Highly Cited
1975
Highly Cited
1975
1 Morphine inhibits the electrically evoked (0.1‐0.15 Hz, 1 ms) contractions of the longitudinal muscle of the mouse vas deferens… 
Highly Cited
1973
Highly Cited
1973
Naltrexone (EN-1639A) is approximately 17 times more potent than nalorphine as an antagonist in man. It is virtually devoid of…